KEY TAKEAWAYS
Probiotics are live bacteria, but they only work if they survive to the colon and match the gut microbiota.
Prebiotics are food for the bacteria the gut already has. They're cheaper, faster, and work for nearly everyone.
Postbiotics are metabolites from dead bacteria. They don't require cold chains and work in India's heat.
Synbiotics combine live bacteria and their food, producing effects stronger than either alone.
Most Indian probiotic supplements fail FSSAI cold-chain standards. By the time they reach consumers, they're already dead.
Millions of Indians buy probiotic supplements every year expecting digestive improvement, energy boosts, or enhanced immunity. Many spend Rs 1,000 to 3,000 monthly on branded probiotic capsules or probiotic curd or yogurt. Yet weeks or months later, nothing changes.
A friend suggests a brand. A gastroenterologist recommends a different strain entirely. A wellness influencer insists the need of 'synbiotic,' not just a probiotic. Online reviews contradict each other wildly.
Probiotics, prebiotics, postbiotics, and synbiotics are fundamentally different things that work through different mechanisms. They're not interchangeable. And understanding the difference determines whether the supplement works or simply becomes wasted money.
A probiotic is a live microorganism (typically Lactobacillus acidophilus, L. rhamnosus, or Bifidobacterium longum) that at adequate doses modifies the gut microbiota (gut microflora) and produces a measurable health benefit. The effective dose depends on the strain and must be scientifically validated for that specific strain and condition.³
Probiotics produce compounds (short-chain fatty acids such as butyrate, acetate, propionate) that strengthen the gut barrier, slow down the unwanted movement of substances across the intestine (intestinal permeability), and regulate immune responses. Some strains (like L. rhamnosus) produce GABA and serotonin precursors, affecting the gut-brain axis.
Effects caused by probiotics are strain-specific and individual-dependent. Whether a strain establishes in an individual's gut depends on the organisms already present in the gut, the kind of diet taken, antibiotic history and genetics. (approximately 60% of colonization success is genetically determined).⁴ This explains high individual variation during research: the same strain produces huge benefits for some people and zero effect for others.
Cost: Rs 500–3,000/month. Requires consistent cold chain (for maintaining temperature during storage and transport). Takes 2–8 weeks for benefits. If stopped, benefits typically disappear within 2–4 weeks.
A prebiotic is a non-digestible food component (inulin, fructooligosaccharides -FOS, galactooligosaccharides -GOS), that selectively stimulates beneficial bacteria growth and activity. There is no new bacteria added, the bacteria already present are adequately fed.
When gut bacteria ferment (micro-organisms convert carbohydrate to acids, gases or alcohol) prebiotic fiber, they produce the same compounds (short-chain fatty acids) as probiotics do. But because prebiotics work with existing microbiota rather than introducing a new strain, individual variation drops. Most individuals are able to ferment prebiotic fibres such as inulin, although the composition of the gut microbiota varies considerably between people and influences the degree of fermentation and short-chain fatty acid production. As a result, many people experience barrier-supporting and immune-modulating benefits, but the response is not identical in every individual.4
Cost: Rs 200–800/month. No cold chain required. Works in 1–2 weeks. Also abundant in common Indian foods: onions, garlic, banana, sugarcane, and jaggery all contain significant prebiotic fiber.
Probiotics are more expensive, require careful cold storage (often compromised in India's heat), take longer to produce benefits, and only work if an individual's microbiota accommodates the strain. Prebiotics are cheaper, thermally stable, faster-acting, and may benefit many people, although individual responses can still vary depending on gut microbiota composition and underlying gastrointestinal conditions. Individuals with irritable bowel syndrome (IBS), particularly those with sensitivity to fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs), may experience worsening bloating, abdominal pain, or gas with certain prebiotics such as inulin.⁸
Yet probiotics dominate the market. The reason is because, probiotics are trademarked, patented products (VSL#3, Align, Culturelle), whereas prebiotics are generic food components. Wellness companies may push probiotics because they're defensible, patentable, and expensive.
A postbiotic is a non-viable microbial component or metabolite produced during fermentation (short-chain fatty acids, bacteriocins, peptidoglycans, vitamins, and bioactive compounds remaining after bacteria die).5 Postbiotics are the byproduct formed which heals the gut.
When Lactobacillus ferments prebiotic fiber, it produces butyrate. That butyrate strengthens intestinal epithelial tight junctions (reduces movement of substances across gut wall), reduces inflammation, and restores gut barrier integrity.
As there are no living organisms, there are no viability or storage concerns. A postbiotic supplement is shelf-stable at room temperature, effective in hot climates, and requires no cold chain.
A 2025 meta-analysis found postbiotics improved the gut barrier and altered the gut organisms composition for metabolic disease management, sometimes matching probiotic efficacy while avoiding storage and transport issues.6
Cost: Rs 600–2,500/month. Ambient-stable. Works in 1–2 weeks.
Limitation: Postbiotics are a newer category still under research to study the evidence of its effects. Though safety data is present, long-term outcome data is limited compared to established probiotics.
A synbiotic is a probiotic strain combined with a prebiotic substrate, rationally designed so they improve each other's effects.
Alone, each faces limits. A probiotic must get established in a competitive environment, difficult and unpredictable. A prebiotic feeds whatever's present, including disease-causing bacteria (pathogenic).
When combined, the prebiotic substrate becomes the probiotic's competitive advantage. That specific probiotic strain preferentially ferments the prebiotic, establishing while starving competing bacteria. Fed by its preferred substrate, the probiotic produces more metabolites than alone. The combined effect exceeds either component independently.7
Cost: Rs 800–3,500/month. Highest cost option. Still requires a cold chain (for the probiotic component).
Best for: Specific conditions with strong evidence (IBD, IBS, atopic dermatitis). Not general wellness.
Although probiotics are generally considered safe for healthy individuals, they are not appropriate for everyone. Rare cases of probiotic-associated bloodstream infections and fungemia have been reported, particularly in people with severe underlying illnesses. Probiotics should be used with caution and only under medical supervision in the following situations:⁹˒¹⁰
People with severe immunocompromise (such as those receiving intensive chemotherapy or with profound immunodeficiency).
Patients with central venous catheters, where rare cases of bloodstream infection have been reported.
Critically ill patients admitted to intensive care units (ICUs).
Patients with severe acute pancreatitis, as some clinical trials have reported increased adverse outcomes with certain probiotic formulations in this setting.¹¹
For these individuals, a physician should determine whether probiotics are appropriate and whether alternative approaches, such as dietary modification or selected postbiotic products, may be more suitable.
Yes. Many fermented foods naturally contain live microorganisms, although not all qualify as probiotics. According to the International Scientific Association for Probiotics and Prebiotics (ISAPP), a food can only be described as containing probiotics when it delivers live microorganisms that have been shown to provide a documented health benefit in adequate amounts.¹²
Examples of fermented foods include:
Yogurt
Curd
Kefir
Kimchi
Sauerkraut
Traditionally fermented dosa and idli batter
These foods can contribute beneficial microorganisms to the diet. However, the microbial strains, viability, and health effects vary widely. Simply being fermented does not automatically make a food a probiotic food unless the microorganisms have been scientifically characterized and shown to provide health benefits.¹²
Food Safety Standards Authority of India (FSSAI) mandates that probiotic products contain a minimum of 10⁶ CFU/ml at point of consumption, maintained through the entire shelf life. In practice, this standard seems to fail consistently across India because:
Cold chains break during transport. For example, a supplement manufactured in Bangalore, shipped uninsulated to Delhi in June, sitting in an unrefrigerated wholesaler warehouse for three weeks, loses 90% viability before retail.
Retail storage is uncontrolled. Most pharmacy shelves lack refrigeration. A probiotic kept at 35°C for four weeks loses 50–70% viability.
Home storage is often neglected. Many consumers don't refrigerate at home. A bottle left on the kitchen counter in Mumbai summer loses viability progressively.
No mandatory third-party verification. Unlike Australia or the USA, India doesn't require independent lab verification of CFU counts at retail. Brands self-test and self-report.
Result: A supplement claiming 10⁸ CFU contains 10⁶ by retail, dropping to 10⁴ after home storage.
Consumers believe they're taking billions of bacteria. When in reality they're taking thousands or sometimes, nothing.
This is precisely why postbiotics are gaining traction in India. Promising efficacy has been reported for several clinical applications while avoiding the viability and cold-chain challenges associated with live microorganisms. However, postbiotics are not interchangeable with probiotics, and evidence varies depending on the specific condition and product.⁵˒⁶
| Condition | Best Option | Evidence Level | Timeline |
|---|---|---|---|
| IBS | Synbiotic or targeted probiotic | Moderate-Strong | 4–8 weeks |
| Atopic dermatitis (children) | Synbiotic or prebiotic | Strong (26% risk reduction) | 6–12 weeks |
| Constipation | Prebiotic (inulin or FOS) | Moderate | 1–2 weeks |
| General microbiota health | Prebiotic (cheaper, universal) | Moderate | 1–2 weeks |
| Immunocompromised | Postbiotic or prebiotic | Moderate | 1–2 weeks |
Probiotics can be effective, but their benefits depend on selecting the right strain, using an evidence-based dose, and ensuring the microorganisms remain viable until they reach the gut.
Prebiotics are often an affordable and practical way to support gut health, although individual responses vary depending on gut microbiota composition and underlying gastrointestinal conditions.
Postbiotics represent an emerging area of research and may offer advantages in situations where storage stability is important, but their clinical applications continue to be evaluated.
Synbiotics may provide added benefit for selected conditions such as irritable bowel syndrome, inflammatory bowel disease, and atopic dermatitis when supported by clinical evidence.
If you are generally healthy and simply looking to support gut health, increasing dietary fibre intake and consuming naturally prebiotic-rich foods may be a practical first step before considering supplements. For conditions such as irritable bowel syndrome, ulcerative colitis, or antibiotic-associated diarrhoea, strain-specific probiotics or synbiotics should be selected with guidance from a gastroenterologist or another qualified healthcare professional.
Food Safety and Standards Authority of India (FSSAI). Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use) Regulations, 2016. Schedule IV: Prebiotics and Probiotics. https://fssai.gov.in/upload/uploadfiles/files
Uhegwu, Chijioke Christopher, and Christian Kosisochukwu Anumudu. "Probiotic Potential of Traditional and Emerging Microbial Strains in Functional Foods: From Characterization to Applications and Health Benefits." Microorganisms 13, no. 11 (2025): 2521. https://doi.org/10.3390/microorganisms13112521.
E. R. Davenport, J. G. Sanders, S. J. Song, K. R. Amato, A. G. Clark, and R. Knight, "The Human Microbiome in Evolution," BMC Biology 15, no. 1 (2017): 127, https://doi.org/10.1186/s12915-017-0454-7.
G. Gibson, R. Hutkins, M. Sanders, et al., "Expert Consensus Document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) Consensus Statement on the Definition and Scope of Prebiotics," Nature Reviews Gastroenterology & Hepatology 14 (2017): 491–502, https://doi.org/10.1038/nrgastro.2017.75.
S. Salminen, M. C. Collado, A. Endo, et al., "The International Scientific Association of Probiotics and Prebiotics (ISAPP) Consensus Statement on the Definition and Scope of Postbiotics," Nature Reviews Gastroenterology & Hepatology 18, no. 9 (2021): 649–667, https://doi.org/10.1038/s41575-021-00440-6.
S. Smolinska, F. D. Popescu, and M. Zemelka-Wiacek, "A Review of the Influence of Prebiotics, Probiotics, Synbiotics, and Postbiotics on the Human Gut Microbiome and Intestinal Integrity," Journal of Clinical Medicine 14, no. 11 (2025): 3673, https://doi.org/10.3390/jcm14113673
D. F. Gomez Quintero, C. R. Kok, and R. Hutkins, "The Future of Synbiotics: Rational Formulation and Design," Frontiers in Microbiology 13 (2022): 919725, https://doi.org/10.3389/fmicb.2022.919725.
McKenzie, Y. A., A. C. Bowyer, A. Leach, G. Gulia, S. Horobin, A. O'Sullivan, K. Pettitt, et al. "British Dietetic Association Systematic Review and Evidence-Based Practice Guidelines for the Dietary Management of Irritable Bowel Syndrome in Adults (2016 Update)." Journal of Human Nutrition and Dietetics 29, no. 5 (2016): 549-575. https://doi.org/10.1111/jhn.12385.
Doron, Shira, and David R. Snydman. "Risk and Safety of Probiotics." Clinical Infectious Diseases 60, suppl. 2 (2015): S129-S134. https://doi.org/10.1093/cid/civ085.
Boyle, Robert J., Robyn M. Robins-Browne, and Mimi L. K. Tang. "Probiotic Use in Clinical Practice: What Are the Risks?" The American Journal of Clinical Nutrition 83, no. 6 (2006): 1256-1264. https://doi.org/10.1093/ajcn/83.6.1256.
Besselink, Marc G. H., et al. "Probiotic Prophylaxis in Predicted Severe Acute Pancreatitis: A Randomised, Double-Blind, Placebo-Controlled Trial." The Lancet 371, no. 9613 (2008): 651-659. https://doi.org/10.1016/S0140-6736(08)60207-X.
Hill, Colin, et al. "Expert Consensus Document. The International Scientific Association for Probiotics and Prebiotics Consensus Statement on the Scope and Appropriate Use of the Term Probiotic." Nature Reviews Gastroenterology & Hepatology 11, no. 8 (2014): 506-514. https://doi.org/10.1038/nrgastro.2014.66.
This article is educational and does not replace consultation with a healthcare provider. Probiotic, prebiotic, postbiotic, and synbiotic selections should be individualized based on your specific condition, medications, and microbiota profile. Consult a gastroenterologist, clinical dietitian, or your primary care physician before starting any supplement.